Figures & data
Table 1 The distribution of migraine diagnosis, primary and secondary migraine medication before stroke, acute coronary syndrome or study entry in patients and population controls.
Figure 1 Associations (Crude and Adjusted OR and 95% CI) between migraine and stroke in 155,216 stroke patients and 156,905 controls.
Table 2 The associations (crude and adjusted OR and 95% CI) of migraine diagnosis and medication with stroke sub types
Table 3 OR and 95% CI for migraine diagnosis, migraine medication use and other types of headache compared with general headache medication use in stroke and acute coronary syndrome patients versus controls
Figure 2 Associations (Crude and Adjusted odds ratio [OR] and 95% CI) between migraine and acute coronary syndrome (ACS) in 97,799 ACS patients and 99,618 controls.
Abbreviation: ACS, acute coronary syndrome.
![Figure 2 Associations (Crude and Adjusted odds ratio [OR] and 95% CI) between migraine and acute coronary syndrome (ACS) in 97,799 ACS patients and 99,618 controls.](/cms/asset/196a14ac-ff78-434d-b808-f620a701877f/dcle_a_144441_f0002_b.jpg)
Table 4 The associations (adjusted OR and 95% CI) of migraine diagnosis and medication with acute coronary heart syndrome sub types
Table S1 ICD 10 and ATC codes used for generation of variables measuring comorbidity, hormones and anti-thrombotic medication
Table S2 The distribution of covariables in relation to migraine diagnosis or medication in 155,216 first-time stroke patients and 156,905 population controls in Denmark 2001–2011
Table S3 The distribution of covariables in relation to migraine diagnosis or medication in 97,799 Danish patients with first time acute coronary heart syndrome (ACS) and 99,618 population controls in Denmark 2001–2009.